Despite HOB Biotech's falling earnings and price, its P/E st...
Despite HOB Biotech's falling earnings and price, its P/E still surpasses the market. Investors remain bullish, unwilling to sell their stock. Yet, if recent earnings trends persist, shareholders and potential investors could face significant risk and overpayment.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000029892192e9300f.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment